Arab Finance: October Pharma (OCPH) has reported a net profit after tax of EGP 108.86 million during the first nine months of 2022, up from EGP 100.32 million in the same period a year earlier, according to the financial statement filed to the Egyptian Exchange (EGX) on November 13th.

Net sales reached EGP 540.86 million in the January-September period of 2022, up from EGP 489.07 million in the same period of 2021.

October Pharma is an Egypt-based company engaged in the production of human pharmaceutical preparations.

The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.